Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 1,817.70
-38.90 (-2.10%)
Jan 8, 2026, 3:20 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 141.13 billion as of January 8, 2026. Its market cap has decreased by -22.37% in one year.
Market Cap
141.13B
Enterprise Value
132.15B
Revenue
20.42B
Ranking
n/a
PE Ratio
23.97
Stock Price
1,817.70
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 141.13B, an increase of 2,520,477.16%. That is a compound annual growth rate of 52.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 141.13B | 0.84% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.28T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.19T |
| Apollo Hospitals Enterprise | 1.07T |
| Mankind Pharma | 954.32B |
| Zydus Lifesciences | 933.33B |
| Aurobindo Pharma | 717.52B |
| Fortis Healthcare | 710.30B |